Articles tagged with Triglycerides
Plozasiran administered by subcutaneous injection every three months has shown substantial reductions in triglyceride levels, with a 78-80% decrease observed after one year. The treatment also demonstrated a significant reduction in acute pancreatitis events, with a 78% decrease in trial populations.
Researchers developed a bioinspired lipid nanoparticle that delivered gene-editing machinery to the liver, reducing low-density lipoprotein (LDL) cholesterol by over 20% and showing fewer signs of inflammation and toxicity. The nanoparticles also demonstrated positive effects on inflammation and healthy blood flow in cell experiments.
Scientists have successfully created programmable supramolecular polymers in neutral lipid environments, such as triolein-rich lipid droplets. This breakthrough provides a new method for regulating cellular functions and has potential applications in treating diseases involving lipid droplets.
A new study finds that the quality of macronutrients matters more than their quantity for heart health, with diets rich in whole grains, fruits, and vegetables associated with a lower risk of coronary heart disease. The study also found improved cardiovascular biomarkers in healthy versions of low-carb and low-fat diets.
A comprehensive scientific review highlights pecans' positive effects on cardiovascular health, including improved lipid metabolism and antioxidant defenses. While findings on blood sugar control are mixed, the review suggests pecans may support better diet quality and satiety.
A recent study published in the Journal of Nutrition found that higher fat diets were more harmful than high-carbohydrate diets, even when fiber supplementation was added. Mice on high-fat and ketogenic diets experienced weight gain, liver damage, and other negative health effects, while those on a high-carbohydrate diet did not.
Scientists developed a compound that targets Liver X Receptor specifically in liver and gut to lower triglycerides. In first-in-human clinical trial, participants showed significant drops in triglycerides and remnant cholesterol after taking the drug.
Approximately one-third of US adults met criteria for metabolic syndrome in 2023, with no significant change in prevalence between 2013 and 2023. Triglyceride levels demonstrated a modest increase over the past decade.
A new medication called DR10624 has shown promising results in reducing high triglyceride levels by over 60% in patients with severe hypertriglyceridemia. The treatment also improved cholesterol and liver health, offering a potential alternative for managing this condition.
In a Phase 1 clinical trial, CRISPR-Cas9 gene-editing therapy CTX310 reduced LDL cholesterol and triglycerides by nearly 50% on average, achieving large reductions in both for the first time. The treatment has shown promise as a one-and-done approach to transform care for patients with lifelong lipid disorders.
Researchers found olezarsen significantly reduced acute pancreatitis incidence by 85% in patients with severely elevated triglyceride levels. The drug also lowered triglyceride levels below 500mg/dL in over 85% of participants.
Researchers found that eating a whole avocado as a nighttime snack led to lower triglyceride levels before and after breakfast compared to other snacks. The study suggests that avocado's unique nutrient package may support heart health by encouraging healthier fat metabolism.
A new study found that nearly one-third of individuals adopting healthy diets didn't lose weight but still experienced significant improvements in cardiometabolic markers, including increased HDL cholesterol and reduced visceral fat. The research suggests a healthy diet can have benefits beyond weight loss.
A new analysis found that oral hormone therapy can lower levels of lipoprotein(a), a genetic risk factor associated with higher risk of heart attack and stroke. Hormone therapy also improved biomarkers of cardiovascular health, including cholesterol levels.
A new study by the University of Surrey found that restricting carbohydrates can lead to improvements in metabolic markers and better handling of high-fat meals. This approach may be more sustainable than extreme calorie restriction, reducing hunger and increasing energy burning.
The study highlights the significant protective role of Asah1 in preventing NAFLD progression by regulating hepatic lipid homeostasis and cellular maintenance processes. The findings suggest that targeting Asah1 expression or activity may inform new therapeutic strategies for improving patient outcomes.
Researchers at the University of Malaga have identified multiple genetic variants causing Familial Chilomicronemia Syndrome, a rare disease characterized by high triglyceride levels. This discovery enables accurate clinical diagnosis and treatment selection for patients with this condition.
Researchers are exploring the effects of herring roe omega-3 on exercise metabolism and recovery in active females. The study aims to investigate its benefits for supporting a healthy lifestyle across all ages, including muscle function, metabolism, and cognitive health.
A large observational study found that high levels of 'good' HDL cholesterol are associated with a heightened risk of glaucoma, particularly among those older than 55. In contrast, higher levels of 'bad' LDL cholesterol, total cholesterol, and triglycerides are linked to a lower risk of the condition.
Consuming 20-30% of daily energy at breakfast is associated with lower body mass index, smaller waist circumference, significantly lower triglyceride levels, and higher HDL cholesterol. A high-quality breakfast with proper balance of proteins, fats, fiber, and nutrients also contributes to reducing cardiovascular risk factors.
Population-level improvements in total cholesterol and triglyceride levels slowed, while adverse trends in glucose levels accelerated in more recent US birth cohorts. Public health initiatives targeting antecedent health behaviors are needed to improve cardiometabolic health across generations.
Researchers developed a noninvasive method to monitor postprandial cardiovascular health using spatial frequency domain imaging (SFDI). The technique effectively tracks diet-induced changes in cardiovascular physiology, revealing significant differences in tissue responses after consuming high-fat and low-fat meals.
A clinical trial led by Mount Sinai researchers shows zodasiran, an RNA inhibitor targeting ANGPTL3, significantly reduces various types of cholesterol and triglycerides. The therapy also lowers apolipoprotein B, a lipid-transporting protein linked to heart disease.
Research finds insulin levels correlate with triglycerides, ApoB, non-HDL cholesterol, and free cholesterol in women with atherosclerotic coronary disease. The study suggests these laboratory-associated flags indicate early coronary atherosclerosis in both diabetic and non-diabetic women.
The randomized clinical trial demonstrates plozasiran's potential to reduce triglyceride levels in patients with severe hypertriglyceridemia. Additional studies are needed to determine its impact on complications associated with the condition.
An experimental treatment further lowers triglyceride levels in patients with moderate to severe hypertriglyceridemia, reducing risk of heart attack and stroke by up to 53%.
A massive study of over 200,000 participants found associations between metabolic dysregulation and long-term risk of depression, anxiety, and stress-related disorders. These findings suggest that individuals with metabolic issues may require closer follow-up for psychiatric diagnosis prevention.
Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.
Rats fed high-fructose diets exhibit disturbances in autonomic nervous and cardiovascular systems, increasing risk of chronic diseases like diabetes and obesity. Fructose consumption by parents is also associated with impaired physiological regulation of their offspring's cardiovascular system.
Researchers found that higher triglyceride levels were associated with a lower risk of developing dementia, with every doubling of levels reducing the risk by 18%. Higher triglycerides also linked to slower cognitive decline over time.
Scientists create molecular model of triglyceride transport in mycobacterial barrier, discovering 'Trojan horse' system to weaken pathogen's defenses. This breakthrough could lead to more effective therapies against tuberculosis.
The International Symposium on Triglyceride/Neutral Lipid and Rare Diseases will explore the molecular and biological diversity of rare diseases due to accumulated triglycerides. The event aims to deepen understanding of these conditions and eliminate isolation by providing disease information and treatment opportunities.
A 4-month randomized controlled trial found that daily intake of resistant starch can lower liver triglycerides and liver enzymes associated with liver injury and inflammation. The treatment group had a different microbiota composition and functionality compared to the control group, leading to improved liver conditions.
A study by Brigham and Women's Hospital found that higher levels of diglycerides and triglycerides are associated with an increased risk of primary open-angle glaucoma. The research suggests that these lipid metabolites play a role in the disease's pathogenesis, highlighting potential new targets for prevention or treatment.
Researchers found that genetic predisposition to lipids, Alzheimer's, and heart disease in the MLXIPL gene locus is shaped by exogenous exposures. Minor alleles of certain variants associated with high triglyceride levels and lower HDL-C levels, which may provide protective effects against Alzheimer's risk.
Researchers found that high-fat diets increase levels of gut-derived bacterial toxins and systemic inflammation, promoting atherosclerosis. The study suggests targeting interventions for individuals at risk of developing heart disease.
Scientists have found that cells break down and reassemble fatty acids to create more beneficial variants, such as oleic acid. This process, called triglyceride cycling, refines poorly usable fatty acids into higher-quality forms.
A study from George Mason University found elevated insulin and hemoglobin A1C levels in early elementary-aged Latino youth with obesity, a risk factor for cardiometabolic diseases. The research aims to identify at-risk children and implement interventions earlier to mitigate the effects of childhood obesity.
A phase 2 study found that ANGPTL3 inhibitor therapy reduced triglycerides by up to 70% in patients with severe hypertriglyceridemia who had previously experienced acute pancreatitis. The treatment, evicanumab-dgnb, also showed potential for cardiovascular prevention by reducing apolipoprotein B levels.
A study found that time-restricted feeding improves muscle performance in obese fruit flies by upregulating genes related to glycine production and utilization. This approach may provide a natural alternative therapy for managing obesity-related pathologies.
Researchers developed a new epigenetic biomarker, GrimAge version 2, which leverages two DNAm-based estimators of plasma proteins to predict mortality risk. The study found that GrimAge 2 outperforms existing clinical biomarkers in predicting mortality across multiple racial/ethnic groups and associations with age-related conditions.
Researchers found shared genetic factors that contribute to severe COVID-19 risk and blood analyte levels. High triglyceride levels were strongly linked to increased risk of severe disease, supporting the use of lipid-lowering drugs against severe COVID-19.
A study of 1779 adolescents found that early-life elevated lipids and dyslipidemia are linked to worsening subclinical atherosclerosis. Conversely, treatment at age 17 effectively halted progression and even reversed it. This critical evidence emphasizes the need for early-life screening and prevention.
A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes, but did not decrease their cardiovascular risk. The study found that lowering triglyceride levels may not protect against cardiovascular disease in people with Type 2 diabetes.
A new study published in Current Opinion in Endocrinology, Diabetes and Obesity suggests that statin therapy is not justified for healthy individuals with high cholesterol. The research found a very weak association between low-density lipoprotein-cholesterol (LDL) and the risk of heart disease and stroke.
Research in rats found that an enriched environment leads to better maternal behavior and higher-quality breastmilk. Mothers in enriching environments had more efficient parenting, resulting in larger offspring with increased body weights and improved social behavior.
A new study found that consuming green tea extract for four weeks can lower blood sugar levels, improve gut health, and decrease inflammation in healthy individuals and those with metabolic syndrome. Researchers observed a significant reduction in fasting blood glucose levels and decreased gut permeability.
Scientists discover that SARS-CoV-2 creates cellular storehouses of fat to replicate and cause disease. Compounds cutting off fatty fuel stop the virus from replicating in lab tests.
Research found that food insecure teens are more likely to attempt weight loss, while college students who drink may compensate with unhealthy eating behaviors. Additionally, studies linked sugar-sweetened beverage consumption to higher triglyceride levels in youth and identified potential mechanisms behind this association.
A study tracking children for up to half a century found five childhood risk factors predict fatal and non-fatal cardiovascular events in adulthood. The findings emphasize the importance of preventive strategies starting in childhood.
Vupanorsen, an experimental drug targeting non-HDL cholesterol, showed modest reductions in Non-HDL cholesterol by up to 28%, triglycerides by up to 57%, and angiopoietin-like 3 (ANGPTL3) levels by up to 95% in patients with high cholesterol.
A new study found that people who have atherothrombotic stroke and high triglyceride levels are at a higher risk of having another stroke or cardiovascular problems one year later. Statin medications can still be an effective treatment for high triglycerides, but diet modifications and exercise may also be necessary to reduce the risk.
Researchers at the University of Virginia Health System have identified a potential way to treat obesity and type 2 diabetes in women by targeting a specific gene called KLF14. Increasing KLF14 abundance in fat cells may help alleviate metabolic abnormalities, including slower metabolic rates and less efficient triglyceride management.
Researchers found that adolescent arterial stiffness may be a causal risk factor for hyperinsulinaemia and insulin resistance in young adulthood. Arterial stiffness also temporally precedes low HDL-cholesterol in young adults, with a positive association with triglyceride levels.
A new study identifies four novel obesity genes and predicts a fifth, using a platform of fat fruit flies. The research found that these genes are involved in a neuronal signaling pathway that increases fat levels.
A review of 25 studies on intermittent fasting found that all forms produced mild to moderate weight loss, similar to traditional calorie-restrictive diets. Intermittent fasting regimens also showed benefits in decreasing blood pressure and insulin resistance, and improving appetite regulation.
A new study found that consuming millets can significantly lower total cholesterol, triglycerides, and BMI, as well as decrease blood pressure in people who were overweight or obese. The study used meta-analysis to analyze data from 19 studies with nearly 900 participants.
The American College of Cardiology has issued clinical guidance on reducing ASCVD risk in patients with persistent hypertriglyceridemia, recommending lifestyle intervention and non-statin therapies. The guidance emphasizes the importance of individualized nutrition guidance for these patients.
Researchers have found 22 lipids linked to lower symptom improvement in people with schizophrenia during treatment. The study's findings suggest a complex interplay between metabolic abnormalities and psychiatric health, highlighting the potential of lipidomics as a promising field for new discoveries.
In a phase 2 trial, evinacumab significantly reduced triglyceride levels in patients with severe hypertriglyceridemia, particularly those with specific genetic mutations. The study found that the magnitude of response was highly dependent on the participant's genetic profile.